Ketogenic Diet Worsens Colitis via Gut Microbiome
New research finds the ketogenic diet worsens colitis in mice by elevating β-hydroxybutyrate, fuelling a harmful gut microbe-immune cascade.
A ketogenic diet (KD) can significantly worsen inflammatory bowel disease (IBD) by triggering a chain reaction involving gut bacteria and immune cells, according to new research published in Nature Communications. Scientists found that elevated levels of the ketone body β-hydroxybutyrate (β-HB) — a hallmark metabolite of KD — fuel the growth of a specific gut microbe that then drives damaging intestinal inflammation in mice.
Why This Matters for Gut Health Research
Inflammatory bowel disease affects millions of people worldwide, and dietary interventions are increasingly explored as complementary treatments. The ketogenic diet, long celebrated for its metabolic and anti-inflammatory benefits, has attracted growing interest among patients and clinicians alike. However, its effects on gut health and the intestinal microbiome have remained poorly understood and contested. This study adds critical nuance, suggesting that a diet widely perceived as broadly anti-inflammatory may carry serious risks for people with compromised intestinal barriers.
How the Ketogenic Diet Disrupts the Gut-Immune Axis
A study published in Nature Communications by Liu and colleagues found that while KD maintained gut homeostasis under normal physiological conditions, it exacerbated colitis when mucosal injury was present. Mechanistically, KD elevated luminal β-hydroxybutyrate, which promoted the expansion of the gut bacterium Thomasclavelia spiroformis. That microbe then activated colonic γδ17 T cells through its cell wall components, ultimately driving IL-17A-mediated intestinal inflammation, according to the researchers. The findings reveal a previously uncharacterised ketogenesis-microbiome-immune cascade that operates specifically under conditions of gut injury.
What This Means for IBD Patients and Microbiome Science
For individuals living with IBD or compromised gut health, the research suggests that adopting a ketogenic diet could inadvertently worsen their condition. The study underscores the broader principle, increasingly recognised in microbiome science, that diet does not affect all individuals equally — context, and specifically gut barrier integrity, shapes how dietary metabolites interact with microbial communities and immune responses. Scientists report that these findings may inform more personalised dietary guidance for IBD patients.
The research, led by Yameng Liu and colleagues at institutions including the National Institutes of Health, highlights the intricate relationship between dietary patterns, the gut microbiome, and systemic immune regulation. As interest in the gut-brain and gut-immune axis continues to grow, studies like this reinforce that popular diets must be evaluated rigorously in the context of specific disease states rather than applied universally.